1-3 of 3
Paul V. Plourde, MD
Close
Sort by
Journal Articles

Preliminary Results Of a Pharmacokinetic Study Of Intravenous Asparaginase Erwinia Chrysanthemi Following Allergy To E Coli -Derived Asparaginase In Children, Adolescents, and Young Adults With Acute Lymphoblastic Leukemia Or Lymphoblastic Lymphoma

Lynda M. Vrooman, MD, Ivan I. Kirov, MD, Zoann E. Dreyer, MD, Michael Kelly, MD, PhD, Nobuko Hijiya, MD, Patrick Brown, MD, Richard A. Drachtman, MD, Yoav H Messinger, MD, A. Kim Ritchey, MD, Gregory A. Hale, MD, Kelly Maloney, MD, Paul V. Plourde, MD, Lewis B. Silverman, MD
Journal: Blood
Blood (2013) 122 (21): 3904.
https://doi.org/10.1182/blood.V122.21.3904.3904
Published: 2013
Journal Articles

L-Asparaginase (L-ASP) Related Toxicities with Asparaginase Erwinia Chrysanthemi in a Large Compassionate Use Protocol.

Paul V. Plourde, MD, Sima Jeha, MD, Nobuko Hijiya, MD, Frank G Keller, MD, Susan R. Rheingold, MD, Zoann E. Dreyer, MD, Gary V. Dahl, MD, Taheri Mercedes, MD, Tim Corn, MD
Journal: Blood
Blood (2012) 120 (21): 2568.
https://doi.org/10.1182/blood.V120.21.2568.2568
Published: 2012
Journal Articles

Administration of Erwinia Asparaginase (Erwinase®) Following Allergy to PEG-Asparaginase In Children and Young Adults with Acute Lymphoblastic Leukemia Treated on AALL07P2 Achieves Therapeutic Nadir Serum Asparaginase Activity: A Report From the Children's Oncology Group (COG)

Wanda Salzer, MD, Barbara Asselin, MD, Jeffrey Supko, PhD, Meenakshi Devidas, PhD, Nicole Kaiser, RPh, Paul V. Plourde, MD, Naomi Winick, MD, Gregory Reaman, MD, Elizabeth Raetz, MD, William L. Carroll, MD, Stephen Hunger, MD
Journal: Blood
Blood (2010) 116 (21): 2134.
https://doi.org/10.1182/blood.V116.21.2134.2134
Published: 2010